Published in Proc Natl Acad Sci U S A on September 01, 1988
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci U S A (1994) 3.24
Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem J (1992) 1.44
An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol (1990) 1.35
The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ Health Perspect (1997) 1.26
Expression of mdr1 and gst-pi in human breast tumours: comparison to in vitro chemosensitivity. Br J Cancer (1990) 1.12
Expression of glutathione S-transferase B1, B2, Mu and Pi in breast cancers and their relationship to oestrogen receptor status. Br J Cancer (1989) 0.95
Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases. Br J Cancer (1992) 0.89
DNA hypermethylation markers of poor outcome in laryngeal cancer. Clin Epigenetics (2010) 0.87
Nucleoside salvage and resistance to antimetabolite anticancer agents. Br J Cancer (1991) 0.87
Transcriptional and post-transcriptional mechanisms can regulate cell-specific expression of the human Pi-class glutathione S-transferase gene. Biochem J (1997) 0.84
The prognostic and predictive power of redox protein expression for anthracycline-based chemotherapy response in locally advanced breast cancer. Mod Pathol (2012) 0.83
DNA hypermethylation profiles in squamous cell carcinoma of the vulva. Int J Gynecol Pathol (2009) 0.83
Time-dependent activity and expression of glutathione S-transferases in the human colon adenocarcinoma cell line Caco-2. Biochem J (1989) 0.82
Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases. Br J Cancer (1996) 0.81
Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases. Br J Cancer (1993) 0.80
Expression of multidrug resistance proteins in invasive ductal carcinoma of the breast. Oncol Lett (2014) 0.79
Decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalan. Br J Cancer (1993) 0.79
Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas. Br J Cancer (1998) 0.77
Inhibition of Akt phosphorylation attenuates resistance to TNF-α cytotoxic effects in MCF-7 cells, but not in their doxorubicin resistant derivatives. Iran J Basic Med Sci (2016) 0.75
Evaluation of glutathione S-transferase Pi in non-invasive ductal carcinoma of breast. Br J Cancer (1994) 0.75
Expression of anionic glutathione S transferase (GST pi) gene in carcinomas of the uterine cervix and in normal cervices. Br J Cancer (1991) 0.75
Two RFLPs at the glutathione S-transferase 3 gene. Nucleic Acids Res (1990) 0.75
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta (1976) 7.41
Assays for differentiation of glutathione S-transferases. Methods Enzymol (1981) 5.69
Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci U S A (1987) 4.43
Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet (1987) 4.28
The glutathione S-transferases: a group of multifunctional detoxification proteins. Adv Enzymol Relat Areas Mol Biol (1978) 3.89
Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science (1983) 3.88
Isolation and expression of a complementary DNA that confers multidrug resistance. Nature (1986) 3.84
Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res (1970) 3.64
Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol (1974) 3.36
Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. Cancer Res (1985) 3.15
Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res (1979) 2.97
Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem (1986) 2.88
Overexpression and amplification of five genes in a multidrug-resistant Chinese hamster ovary cell line. Mol Cell Biol (1986) 2.59
Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet (1985) 2.44
Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci U S A (1985) 2.32
Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia. Science (1987) 2.17
Cloning and the nucleotide sequence of rat glutathione S-transferase P cDNA. Nucleic Acids Res (1985) 2.15
Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival. Cancer Res (1980) 1.92
Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol Endocrinol (1987) 1.72
Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proc Natl Acad Sci U S A (1986) 1.71
Cellular biochemistry of the stepwise development of cancer with chemicals: G. H. A. Clowes memorial lecture. Cancer Res (1984) 1.70
Prediction of early course of breast carcinoma by thymidine labeling. Cancer (1983) 1.61
The resistance of putative premalignant liver cell populations, hyperplastic nodules, to the acute cytotoxic effects of some hepatocarcinogens. Cancer Res (1976) 1.58
Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res (1987) 1.49
Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. Eur J Cancer (1981) 1.36
Increased synthesis of a low molecular weight protein in vincristine-resistant cells. Biochem Biophys Res Commun (1981) 1.36
Alteration of plasma membrane glycopeptides and gangliosides of Chinese hamster cells accompanying development of resistance to daunorubicin and vincristine. Cancer Res (1983) 1.33
Human placental form of glutathione S-transferase (GST-pi) as a new immunohistochemical marker for human colonic carcinoma. Jpn J Cancer Res (1986) 1.30
Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Science (1987) 1.28
Epidermal growth factor receptors in human breast cancer. Breast Cancer Res Treat (1984) 1.21
Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc Natl Acad Sci U S A (1987) 1.21
Differential amplification and disproportionate expression of five genes in three multidrug-resistant Chinese hamster lung cell lines. Mol Cell Biol (1986) 1.20
Comparison of anthracycline concentrations in S180 cell lines of varying sensitivity. Eur J Cancer Clin Oncol (1983) 1.14
Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards. Cancer Treat Rep (1985) 1.13
Markedly altered membrane transport and intracellular binding of vincristine in multidrug-resistant Chinese hamster cells selected for resistance to vinca alkaloids. J Cell Physiol (1986) 1.09
Practical breast carcinoma cell kinetics: review and update. Breast Cancer Res Treat (1984) 1.07
Glutathione S-transferases in nitrogen mustard-resistant and -sensitive cell lines. Mol Pharmacol (1987) 1.06
Correlations between anthracycline resistance, drug accumulation and membrane glycoprotein patterns in solid tumors of mice. Cancer Lett (1985) 0.98
Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard. Cancer Res (1987) 0.94
Glutathione-S-transferase gene mapped to chromosome 11 is GST3 not GST1. Somat Cell Mol Genet (1984) 0.91
Promoter-glutathione S-transferase Ya cDNA hybrid genes. Expression and conferred resistance to an alkylating molecule in mammalian cells. J Biol Chem (1987) 0.88
Identification of a characteristic cytosolic polypeptide of rat preneoplastic hepatocyte nodules as placental glutathione S-transferase. Biochem Biophys Res Commun (1987) 0.84
Correlation of estrogen receptors and response to chemotherapy of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in advanced breast cancer. Cancer (1981) 0.82
Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med (1985) 8.45
Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci U S A (1994) 6.74
Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med (1989) 6.37
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med (1989) 6.24
Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science (1988) 4.26
Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures. Proc Natl Acad Sci U S A (1969) 3.72
Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med (1995) 3.43
Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science (1977) 3.11
Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature (1990) 3.11
Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases. Clin Pharmacol Ther (1987) 2.92
Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res (1983) 2.90
Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem (1986) 2.88
PIK3CA as an oncogene in cervical cancer. Oncogene (2000) 2.75
Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res (1995) 2.74
Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res (1987) 2.67
Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep (1978) 2.42
The pharmacology and clinical use of methotrexate. N Engl J Med (1983) 2.29
Fraud in breast-cancer trials. N Engl J Med (1994) 2.28
Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. Proc Natl Acad Sci U S A (1988) 2.26
Chromosome translocation in peripheral neuroepithelioma. N Engl J Med (1984) 2.22
Identification and isolation of a membrane protein necessary for leukotriene production. Nature (1990) 2.20
Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides. N Engl J Med (1989) 2.17
Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet (1986) 2.04
Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience. J Clin Oncol (1989) 2.03
Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. J Clin Invest (1980) 2.03
Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells. Mol Cell Biol (1985) 2.02
Influence of Dead Bacteria on Microscopic Counts of Pasteurized Milk. Am J Public Health Nations Health (1937) 2.02
Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23). Science (1982) 2.02
The anthracycline antineoplastic drugs. N Engl J Med (1981) 2.02
Cortico-striatal contributions to feedback-based learning: converging data from neuroimaging and neuropsychology. Brain (2004) 2.00
A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med (1989) 1.99
5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J Exp Med (1993) 1.95
Second malignancies complicating Hodgkin's disease in remission. Lancet (1975) 1.90
Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res (1989) 1.86
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin Cancer Res (1996) 1.82
Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci U S A (1998) 1.74
Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem Biophys Res Commun (2000) 1.73
Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res (1994) 1.73
Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells. Clin Cancer Res (1995) 1.72
Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proc Natl Acad Sci U S A (1986) 1.71
Basal ganglia and dopamine contributions to probabilistic category learning. Neurosci Biobehav Rev (2007) 1.70
T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol (1992) 1.69
Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci U S A (1985) 1.66
Multidrug resistance. J Natl Cancer Inst (1988) 1.63
A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). Cancer Genet Cytogenet (1982) 1.61
Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer. Am J Med (1995) 1.60
Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res (1990) 1.57
BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J Biol Chem (2000) 1.57
Hippocampal mediation of stimulus representation: a computational theory. Hippocampus (1993) 1.55
Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer. Cancer Res (1979) 1.55
Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. J Biol Chem (1990) 1.54
Pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS and related disorders. J Clin Pharmacol (1988) 1.51
Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res (1997) 1.50
Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res (1987) 1.49
Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols. Cancer Res (1983) 1.47
Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin. Proc Natl Acad Sci U S A (1984) 1.46
Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. J Clin Invest (1981) 1.46
Suramin: an anticancer drug with a unique mechanism of action. J Clin Oncol (1989) 1.45
Suramin-induced skin reactions. Arch Dermatol (1992) 1.45
Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res (1981) 1.45
Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci U S A (1994) 1.44
Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomes. N Engl J Med (1983) 1.44
Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res (1995) 1.43
Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer. J Clin Oncol (2000) 1.43
Adsorption protein of the bacteriophage fd: isolation, molecular properties, and location in the virus. Biochemistry (1977) 1.42
Mode of action of 5-fluorocytosine. Biochem Pharmacol (1978) 1.40
Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial. Ann Intern Med (1987) 1.39
Role of the basal ganglia in category learning: how do patients with Parkinson's disease learn? Behav Neurosci (2004) 1.38
5-lipoxygenase-activating protein is an arachidonate binding protein. FEBS Lett (1993) 1.35
An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol (1990) 1.35
The clinical pharmacology of antineoplastic agents (first of two parts). N Engl J Med (1975) 1.35
Depression and body image following mastectomy and lumpectomy. J Chronic Dis (1987) 1.34
Philadelphia-chromosome-positive preleukaemic state. Lancet (1972) 1.33
Phase I study of phenylacetate administered twice daily to patients with cancer. Cancer (1995) 1.33
Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors. N Engl J Med (1983) 1.32
Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ (1996) 1.32
Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy. Cancer Res (1988) 1.32
Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun (1997) 1.31
Infectious mononucleosis: continuous suspension culture of peripheral blood leucocytes. Nature (1968) 1.31
Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells. N Engl J Med (1978) 1.30
Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins. Mol Pharmacol (1989) 1.29
Structure of the human neutrophil elastase gene. J Biol Chem (1988) 1.28
Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex. Clin Pharmacol Ther (1989) 1.27
The human liver glutathione S-transferase gene superfamily: expression and chromosome mapping of an Hb subunit cDNA. Nucleic Acids Res (1988) 1.27
DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sézary syndrome. J Clin Invest (1980) 1.26
Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Cancer Res (1995) 1.26
Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). Blood (1968) 1.26
"Silent" nucleotide substitution in a beta+-thalassemia globin gene activates splice site in coding sequence RNA. Proc Natl Acad Sci U S A (1983) 1.25
A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. J Biol Chem (1994) 1.23
The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials. Ann Surg (1984) 1.22